Johns Hopkins HIV Guide
Efavirenz
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretroviral agents in adults and pediatric patients at least 3 months old and weighing at least 3.5 kg
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 3, 2019
Citation
Bernice, Fidelia. "Efavirenz." Johns Hopkins HIV Guide, The Johns Hopkins University, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545062/5.2/Efavirenz.
Bernice F. Efavirenz. Johns Hopkins HIV Guide. The Johns Hopkins University; 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545062/5.2/Efavirenz. Accessed October 31, 2025.
Bernice, F. (2019). Efavirenz. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545062/5.2/Efavirenz
Bernice F. Efavirenz [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2019. [cited 2025 October 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545062/5.2/Efavirenz.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Efavirenz
ID - 545062
A1 - Bernice,Fidelia,Pharm.D.
Y1 - 2019/09/03/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545062/5.2/Efavirenz
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
